Safety and immunogenicity of Chiron/Biocine® recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers

Pediatric Infectious Disease Journal

Volumn 16, Issue 1, 1997, Pages 53-58

  Black, Steven B ^a,c   Shinefield, Henry R ^a   Bergen, Randy ^a   Hart, Cary ^a   Kremers, Robert ^a   Lavetter, Allan ^a   Lemesurier, Jim ^a   Morozumi, Pius A ^a   Ray, Paula ^a   Lewis, Edwin M ^a   Fireman, Bruce ^a   Schwalbe, Joan ^a   Hallam, Patricia ^a   Shandling, Mitchell ^a   Dekker, Cornelia ^b   Granoff, Dan M ^b   Izu, Allen ^b   Podda, Audino ^b  

^a KAISER PERMANENTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Acellular pertussis vaccine; infants; safety

Indexed keywords

BIOCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEVER; HUMAN; IMMUNOGENICITY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROTOXICITY; PERTUSSIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; TETANUS; VACCINATION;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOUBLE-BLIND METHOD; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; PROSPECTIVE STUDIES;

EID: 8044259002     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199701000-00012     Document Type: Article

References (6)

1. Recommendation of the Immunization Practices Advisory Committee: diphtheria, tetanus and pertussis. MMWR 1985; 34:405-26.
2. Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR, Nature and rates of adverse reactions associated with DTP and DT immunization in infants and children. Pediatrics 1981;68:650-60.
3. Pizza M, Covacci A, Bartoloni A, et al. Mutants of pertussis toxin suitable for vaccine development. Science 1989;246: 497-500.
4. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.
5. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of census based methodology. Am J Public Health 1992;82:703-10.
6. Blyth CR, Still HA. Binomial confidence intervals. J Am Stat Assoc 1983;78:108-16.